Newtech Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.85 M
About Newtech Pharmaceuticals
Newtech Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2016 (Eight years and eight months 16 days old ). Its registered office is in Saharanpur, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹3.85 M.
Atul Arora and Neerja Arora serve as directors at the Company.
Company Details
- Location
Saharanpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290UP2016PTC083928
- Company No.
083928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Newtech Pharmaceuticals Private Limited offer?
Newtech Pharmaceuticals Private Limited offers a wide range of products and services, including Animal Feed Supplement, Feed Supplement, Poultry Feed Supplements, Healthcare Products & Aids, Health Drinks, Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Cattle Feed Additives, Liquid Calcium.
Who are the key members and board of directors at Newtech Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Arora  | Director | 09-Jun-2016 | Current |
| Neerja Arora | Director | 09-Jun-2016 | Current |
Financial Performance of Newtech Pharmaceuticals.
Newtech Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Newtech Pharmaceuticals?
Unlock access to Newtech Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.85 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2019 | Yes Bank Limited | ₹3.85 M | Open |
How Many Employees Work at Newtech Pharmaceuticals?
Unlock and access historical data on people associated with Newtech Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newtech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newtech Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.